Glucose and aging control the quiescence period that follows pancreatic beta cell replication.
Pancreatic beta cell proliferation has emerged as the principal mechanism for homeostatic maintenance of beta cell mass during adult life. This underscores the importance of understanding the mechanisms of beta cell replication and suggests novel approaches for regenerative therapy to treat diabetes. Here we use an in vivo pulse-chase labeling assay to investigate the replication dynamics of adult mouse beta cells. We find that replicated beta cells are able to re-enter the cell division cycle shortly after mitosis and regain their normal proliferative potential after a short quiescence period of several days. This quiescence period is lengthened with advanced age, but shortened during injury-driven beta cell regeneration and following treatment with a pharmacological activator of glucokinase, providing strong evidence that metabolic demand is a key determinant of cell cycle re-entry. Lastly, we show that cyclin D2, a crucial factor in beta cell replication, is downregulated during cell division, and is slowly upregulated post-mitosis by a glucose-sensitive mechanism. These results demonstrate that beta cells quickly regain their capacity to re-enter the cell cycle post-mitosis and implicate glucose control of cyclin D2 expression in the regulation of this process.
Salpeter
Seth J
SJ
Department of Developmental Biology and Cancer Research and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Klein
Allon M
AM
Huangfu
Danwei
D
Grimsby
Joseph
J
Dor
Yuval
Y
D000375:Aging; D000818:Animals; D002453:Cell Cycle; D049109:Cell Proliferation; D016922:Cellular Senescence; D056742:Cyclin D2 / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D050417:Insulin-Secreting Cells / Q000166:cytology / Q000378:metabolism*; D051379:Mice
D056742:Cyclin D2; D005947:Glucose
Dev Cell. 2009 Jul;17(1):142-9
19619499
Mol Cell Biol. 2005 May;25(9):3752-62
15831479
Diabetes. 2000 Aug;49(8):1325-33
10923633
Diabetes. 2008 Jun;57(6):1584-94
18334605
Diabetes. 2008 Apr;57(4):958-66
18083786
Am J Pathol. 1991 Apr;138(4):867-73
2012175
J Clin Invest. 2004 Sep;114(6):828-36
15372107
J Clin Invest. 2007 Sep;117(9):2553-61
17786244
Diabetes. 1995 Mar;44(3):249-56
7883109
Development. 2009 Nov;136(21):3567-74
19793886
J Clin Invest. 2004 Oct;114(7):963-8
15467835
Genes Dev. 2007 Apr 1;21(7):756-69
17403778
J Clin Pathol. 1993 Dec;46(12):1080-4
7506714
PLoS Biol. 2007 Jul;5(7):e163
17535113
Genes Dev. 1993 May;7(5):812-21
8491378
Diabetes. 2009 Jun;58(6):1365-72
19265026
Cell Cycle. 2006 Feb;5(3):234-7
16410729
Diabetologia. 2006 Aug;49(8):1838-44
16802132
Genes Dev. 2009 Apr 15;23(8):975-85
19390090
N Engl J Med. 2006 Sep 28;355(13):1318-30
17005949
Science. 2003 Jul 18;301(5631):370-3
12869762
Nat Clin Pract Endocrinol Metab. 2007 Nov;3(11):758-68
17955017
Dev Cell. 2007 May;12(5):817-26
17488631
Nature. 2006 Sep 28;443(7110):453-7
16957737
Oncogene. 1994 Mar;9(3):707-18
8108113
Diabetes. 2005 Sep;54(9):2557-67
16123343
Diabetes. 2009 Jun;58(6):1312-20
19228811
Diabetes. 2007 Jul;56(7):1792-801
17400928
Nature. 2004 May 6;429(6987):41-6
15129273
Genes Dev. 2009 Apr 15;23(8):906-11
19390085
Endocrinology. 1992 Mar;130(3):1459-66
1537300